The Epidermal Growth Factor Receptor Responsive miR-125a Represses Mesenchymal Morphology in Ovarian Cancer Cells

被引:138
作者
Dahl, Karen D. Cowden [1 ]
Dahl, Richard [2 ]
Kruichak, Jessica N.
Hudson, Laurie G.
机构
[1] Univ New Mexico, Coll Pharm, Hlth Sci Ctr, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA
来源
NEOPLASIA | 2009年 / 11卷 / 11期
基金
美国国家卫生研究院;
关键词
PROGNOSTIC VALUE; E-CADHERIN; EXPRESSION; MATRIX-METALLOPROTEINASE-9; DIFFERENTIATION; TRANSFORMATION; REQUIREMENTS; TRANSITION; CARCINOMA; FAMILY;
D O I
10.1593/neo.09942
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epithelial-to-mesenchymal transition (EMT) that occurs during embryonic development is recapitulated during tumor metastasis. Important regulators of this process include growth factors, transcription factors, and adhesion molecules. New evidence suggests that microRNA (miRNA) activity contributes to metastatic progression and EMT; however, the mechanisms leading to altered miRNA expression during cancer progression remain poorly understood. Importantly, overexpression of the epidermal growth factor receptor (EGFR) in ovarian cancer correlates with poor disease outcome and induces EMT in ovarian cancer cells. We report that EGFR signaling leads to transcriptional repression of the miRNA miR-125a through the ETS family transcription factor PEA3. Overexpression of miR-125a induces conversion of highly invasive ovarian cancer cells fromamesenchymal to an epithelialmorphology, suggesting miR-125a is a negative regulator of EMT. We identify AT-rich interactive domain 3B (ARID3B) as a target of miR-125a and demonstrate that ARID3B is overexpressed in human ovarian cancer. Repression of miR-125a through growth factor signaling represents a novel mechanism for regulating ovarian cancer invasive behavior.
引用
收藏
页码:1208 / U124
页数:9
相关论文
共 24 条
[1]   The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer [J].
Bartlett, JMS ;
Langdon, SP ;
Simpson, BJB ;
Stewart, M ;
Katsaros, D ;
Sismondi, P ;
Love, S ;
Scott, WN ;
Williams, ARW ;
Lessells, AM ;
Macleod, KG ;
Smyth, JF ;
Miller, WR .
BRITISH JOURNAL OF CANCER, 1996, 73 (03) :301-306
[2]   RECEPTORS FOR HORMONES AND GROWTH-FACTORS AND (ONCO)-GENE AMPLIFICATION IN HUMAN OVARIAN-CANCER [J].
BERNS, EMJJ ;
KLIJN, JGM ;
HENZENLOGMANS, SC ;
RODENBURG, CJ ;
VANDERBURG, MEL ;
FOEKENS, JA .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (02) :218-224
[3]   Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells [J].
Dahl, Karen D. Cowden ;
Symowicz, Jaime ;
Ning, Yan ;
Gutierrez, Elisa ;
Fishman, David A. ;
Adley, Brian P. ;
Stack, M. Sharon ;
Hudson, Laurie G. .
CANCER RESEARCH, 2008, 68 (12) :4606-4613
[4]   PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells [J].
Dahl, Karen D. Cowden ;
Zeineldin, Reema ;
Hudson, Laurie G. .
MOLECULAR CANCER RESEARCH, 2007, 5 (05) :413-421
[5]  
Davidson B, 2003, CLIN CANCER RES, V9, P1412
[6]  
Ellerbroek SM, 2001, CANCER RES, V61, P1855
[7]  
Ellerbroek SM, 1998, INT J CANCER, V78, P331, DOI 10.1002/(SICI)1097-0215(19981029)78:3<331::AID-IJC13>3.0.CO
[8]  
2-9
[9]   The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 [J].
Gregory, Philip A. ;
Bert, Andrew G. ;
Paterson, Emily L. ;
Barry, Simon C. ;
Tsykin, Anna ;
Farshid, Gelareh ;
Vadas, Mathew A. ;
Khew-Goodall, Yeesim ;
Goodall, Gregory J. .
NATURE CELL BIOLOGY, 2008, 10 (05) :593-601
[10]   Differential gene expression in ovarian carcinoma - Identification of potential biomarkers [J].
Hibbs, K ;
Skubitz, KM ;
Pambuccian, SE ;
Casey, RC ;
Burleson, KM ;
Oegema, TR ;
Thiele, JJ ;
Grindle, SM ;
Bliss, RL ;
Skubitz, APN .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (02) :397-414